Related Experiment Video
Updated: May 13, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Online multimedia teaching tool for Parkinson's disease.
Greg Misiaszek1, Michelle Riconscente, Maria Henke
1Davis School of Gerontology.
Summary
This study introduces an online, multi-sensory learning tool for neurosciences education. The tool enhances student engagement and knowledge retention for complex topics like Parkinson's disease (PD).
Area of Science:
- Neuroscience Education
- Medical Education Technology
Background:
- Traditional neuroscience education struggles with complex concepts.
- Multi-sensory engagement can improve learning and knowledge retention.
Purpose of the Study:
- To develop and evaluate an online multimedia tool for neurosciences education.
- To enhance student learning through multi-sensory engagement and visualization of complex neural processes.
Main Methods:
- Developed an online multimedia tool with scrolling text, narration, and visual imagery.
- Integrated 2D/3D animations, video clips, and supplemental readings (PDFs).
- Structured content with outline format and drop-down menus for layered learning.
Main Results:
- The tool facilitates multi-sensory learning, aiding visualization of complex nervous system processes.
- Initial application focuses on Parkinson's disease (PD) instruction.
- Flexible design allows adaptation for various subjects and supplemental course use.
Conclusions:
- The online tool effectively enhances the student learning environment in neurosciences.
- Multi-modal engagement improves knowledge encoding, storage, and retrieval.
- The tool offers a flexible, accessible resource for instructors and students.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...